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HIGHLIGHTS 
Asymmetrical use of hind limb was assessed in unilateral 6-OHDA-lesioned mice. 
A significantly decreased number of the contralateral stepping was observed.  
Levodopa reversed the asymmetry of hind limb in a dose dependent manner.  





Unilateral injection of 6-hydroxydopamine (6-OHDA) is commonly used to generate a 33 
rodent model of Parkinson’s disease (PD). Although motor deficits of the lower 34 
extremities represent one of the major clinical symptoms in PD patients, validated tests 35 
for assessing motor impairments of the hind limb in 6-OHDA mice are currently 36 
unavailable. We here report the video-based assessments of the asymmetric use of hind 37 
limbs in 6-OHDA mice. A significantly decreased number of spontaneous hind limb 38 
stepping was observed in the contralateral-to-lesioned side, and was dose dependently 39 
reversed by levodopa, suggesting that it could be utilized for screening PD therapeutics. 40 
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Parkinson’s disease (PD) is characterized by a wide variety of motor deficits 44 
due to striatal dopamine depletion, which is caused by a progressive loss of nigrostriatal 45 
dopamine (DA)-producing cells (Fahn et al., 1987; Samii et al., 2004). Administration 46 
of the DA precursor levodopa or dopamine receptor agonists is a major 47 
pharmacotherapy for PD. To investigate mechanisms of pathogenesis and 48 
pathophysiology, and to develop novel therapeutics, animal models of PD induced by 49 
chemicals are widely used (Bové and Perier, 2012). The 6-hydroxydopamine 50 
(6-OHDA)-lesioned unilateral PD model, originally established in rats (Ungerstedt, 51 
1968), can also be applied to mice (Iancu et al., 2005). Injecting 6-OHDA unilaterally 52 
into the substantia nigra pars compacta (SNpc), dorsal striatum (ST), or medial 53 
forebrain bundle (MFB) causes robust reduction in striatal DA via loss of nigrostriatal 54 
dopaminergic neurons, and is accompanied by marked motor asymmetry known as 55 
hemi-parkinsonism (Ungerstedt, 1968; Iancu et al., 2005; Heuer et al., 2012). 56 
Behavioral indexes to evaluate motor deficiency related to PD and to levodopa-induced 57 
dyskinesia (LID), initially established in rats, have been developed in mice (Iancu et al., 58 
2005; Heuer et al., 2012; Glajch et al., 2012).  Among them, rotational activity is 59 
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commonly used to examine motor deficits and the efficacy of PD therapeutics. In this 60 
model, animals receive a unilateral 6-OHDA lesion to increase spontaneous rotational 61 
activity in the ipsilateral-to-lesioned side. Amphetamine increases this activity in 62 
proportion to the number of surviving nigrostriatal dopaminergic neurons, whereas 63 
apomorphine or levodopa reverses this effect in the contralateral-to-lesioned side in 64 
proportion to the loss of nigrostriatal dopaminergic neurons (Ungerstedt and Arbuthnott, 65 
1970; Heuer et al., 2012; Glajch et al., 2012). The motor impairments observed in the 66 
contralateral-to-lesioned side of these animals are characterized by reduced limb use 67 
(Miklyaeva and Whishaw, 1996; Glajch et al., 2012). Forelimb impairment can be 68 
validated by the cylinder and stepping tests (Olsson et al., 1995; Iancu et al., 2005; 69 
Blume et al., 2009; Heuer et al., 2012), which reveal decreased use of the contralateral 70 
forelimb. This effect is ameliorated by PD therapeutic agents such as levodopa or 71 
bromocriptine (Lunblad et al., 2002; Francardo et al., 2011). In contrast to the forelimb, 72 
however, hind limb impairment in 6-OHDA-lesioned mice has not been sufficiently 73 
characterized. Considering that motor deficits of the lower extremities represent a major 74 
clinical symptom in patients with PD (Fahn et al., 1987), it is reasonable to validate 75 
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whether hind limb impairment could be an index that reflects motor deficiency in 76 
6-OHDA-lesioned mice. Using video-based analysis, we characterized the asymmetrical 77 
use of hind limb on spontaneous steps and the effect of levodopa on this behavior in 78 
unilateral 6-OHDA-lesioned mice. 79 
Subjects were male C57BL/6N mice aged 8 weeks (Japan SLC, Shizuoka, 80 
Japan) housed in a controlled environment (25 ± 1°C, 50 ± 1% humidity) with food and 81 
tap water available ad libitum. The room lights were on between 8:30 and 20:30. All 82 
experiments were performed with the approval of the Institutional Animal Care and Use 83 
Committees of Tokushima University, Japan, and in accordance with the NIH 84 
guidelines for the care and use of animals. 85 
The hemi-parkinsonian model mice by 6-OHDA were made according to the 86 
protocol reported previously (Thiele et al., 2011). Mice received an intraperitoneal (i.p.) 87 
injection of desipramine hydrochloride (1 mg/kg dissolved in 0.9% saline, Wako, Osaka, 88 
Japan) and pargyline hydrochloride (0.2 mg/kg dissolved in 0.9% saline, Sigma-Aldrich, 89 
St. Louis, MO, USA). After 15 min, they were anesthetized with isoflurane (MSD 90 
Animal Health, Whitehouse Station, NJ, USA), 70% N2O, and 30% O2, and were 91 
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mounted on the stereotaxic frame (NARISHIGE, Tokyo, Japan). Each mouse received 92 
an injection of 6-OHDA (3 µg in 0.9% saline containing 0.2% ascorbic acid, 93 
Sigma-Aldrich, St. Louis, MO, USA) targeting the right MFB (from bregma: AP -1.2 94 
mm, ML +1.1 mm, DV +5.0 mm). It was administered at 0.24 µl/min using a 95 
microsyringe (Hamilton, Bonaduz, GR, Switzerland), which was removed 5 min after 96 
injection. 97 
Fourteen days post 6-OHDA injection, spontaneous rotations were measured 98 
for 30 min in a 2-litre beaker. Mice with over 80% ipsilateral rotations were used in this 99 
study. To measure apomorphine-induced rotation, mice further received a single i.p. 100 
injection of apomorphine (0.5 mg/kg dissolved in 0.9% saline containing 0.2 mg/mL 101 
ascorbic acid, Sigma-Aldrich, St. Louis, MO, USA). Control mice received an 102 
equivalent volume of 0.9% saline. Levodopa-induced rotation was evaluated for 5 min 103 
in the same experimental condition with the hind limb step analysis described below. 104 
 Mice received a single i.p. injection of levodopa (1 or 3 mg/kg of free base 105 
dissolved in 0.9% saline containing 0.5% carboxymethyl cellulose; Sigma-Aldrich, St. 106 
Louis, MO, USA) 15 days after the 6-OHDA injection. An equivalent volume of 0.9% 107 
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saline containing 0.5% carboxymethyl cellulose was injected in control mice. All mice 108 
were pre-treated with a single i.p. injection of benserazide (12.5 mg/kg; Sigma-Aldrich, 109 
St. Louis, MO, USA) dissolved in 0.9% saline 20 min before the administration of 110 
levodopa or saline. 111 
 Ten minutes after administration of levodopa, spontaneous steps were 112 
video-recorded from the bottom of a 600 mL beaker for 5 min. Each hind limb step was 113 
counted manually using a playback speed slowed to 0.3–0.5× using VLC media player. 114 
Total hind limb steps were summed for both the ipsilateral (intact) and contralateral 115 
(impaired) sides, and the number of contralateral steps was calculated as a % of the 116 
count. Further, sequential use of the ipsilateral hind limb was independently counted, 117 
with two sequential steps defined as double and three steps as triple. The video-analysis 118 
was performed by examiners who unaware of the grouping information of mice. 119 
Mouse tissue was fixed by circulating 4% paraformaldehyde (Wako, Osaka, 120 
Japan) dissolved in phosphate-buffered saline (PBS) 16 days after 6-OHDA injection. 121 
Immunostaining was conducted using free-floating sections and the tyramide signal 122 
amplification (TSA) method. After blocking endogenous peroxidase activity, the 123 
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sections were incubated in PBS containing 3% bovine serum albumin for 60 min, and 124 
then incubated with primary antibody against tyrosine hydroxylase (TH, rabbit 125 
polyclonal, 1:200,000, Chemicon, CA, USA) for 18 h. Antigens were detected using the 126 
Histofine Simple Stain kit (Nichirei, Tokyo, Japan) and TSA-system with Fluorescein 127 
(Perkin Elmer, Shelton, CT, USA). Immunofluorescence-stained images were captured 128 
using a fluorescence microscope (BZ-9000, Keyence, Tokyo, Japan). Measurement of 129 
TH-immunopositive density in the ST was performed using an image analyzer 130 
(WinRoof Ver.5, Mitani, Fukui, Japan), and the averaged pixel intensities (16-bit) were 131 
expressed with arbitrary unit. 132 
All experimental values are expressed as means ± SEM. For two-group 133 
comparisons, a paired two-tailed t-test was used. For multiple comparisons, one-way 134 
analysis of variance (ANOVA) followed by Scheffe’s post hoc test was used unless 135 
otherwise stated. Statistical analysis was performed using Stat View 5.0 (SAS Institute, 136 
Cary, USA). 137 
 Fourteen days after mice received a unilateral injection of 6-OHDA into the 138 
MFB, spontaneous and apomorphine-induced rotations were assessed (Figure 1A). 139 
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Spontaneous rotations in the contralateral-to-lesioned side, indicated as % of total (sum 140 
of ipsi- and contralateral rotations), were significantly less common in 141 
6-OHDA-lesioned mice than in control mice (control, 55.1 ± 2.5%; 6-OHDA, 5.9 ± 142 
3.6%; n = 5, P < 0.005). Conversely, 6-OHDA-lesioned mice that received 143 
apomorphine showed reversal of this laterality, with significantly more frequent rotation 144 
in the contralateral side than control mice (100 ± 0%, n = 5, P < 0.005 vs. control). 145 
Immunohistochemical analysis revealed robustly lower TH immunoreactivity (IR) in 146 
the ipsilateral-to-lesioned side of the ST than in the contralateral non-lesioned side 147 
(Figure 1B). Quantitative analysis showed approximately 70% significantly lower TH 148 
IR in the lesioned side than in the non-lesioned side (lesioned side, 7503.2 ± 385.8; 149 
non-lesioned side, 2199.6 ± 107.7; n = 5, P < 0.005), as shown in Figure 1C (arbitrary 150 
unit). 151 
We next analyzed spontaneous hind limb steps 1 day after examination of 152 
rotational behavior. Figure 2A shows the topological configuration of the hind limb 153 
analyzed. The number of steps taken by the hind limb is shown in Figure 2B. The total 154 
number of hind limb steps was not significantly different between control (121.8 ± 13.3; 155 
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n = 5) and 6-OHDA-lesioned mice (137.6 ± 22.2; n = 5, P > 0.05). Levodopa 156 
dose-dependently increased total hind limb steps in 6-OHDA-lesioned mice (1 mg/kg of 157 
levodopa, 226.4 ± 82.3, P > 0.05; 3 mg/kg of levodopa, 516.4 ± 118.5, n = 5, P < 0.05 158 
vs. control or 6-OHDA). 159 
As shown in Figure 2C, the percent use of the contralateral-to-lesioned side of 160 
the hind limb relative to total steps was significantly decreased by 6-OHDA-induced 161 
lesions (control, 54.0 ± 1.64; 6-OHDA, 38.5 ± 1.09; n = 5, P < 0.05). Levodopa was 162 
shown to dose-dependently reverse this decrease (1 mg/kg of levodopa, 53.7 ± 5.08, P < 163 
0.05 vs. 6-OHDA; 3 mg/ kg of levodopa, 65.2 ± 4.33, P < 0.005 vs. 6-OHDA). 164 
Additionally, we analyzed the sequential use of the ipsilateral-to-lesioned side of hind 165 
limb by counting double and triple steps. In 6-OHDA-lesioned mice, it tended to 166 
increase, probably due to the compensatory response to the disabled movement in the 167 
contralateral side, and was also reversed by levodopa with a dose-dependent manner 168 
(Supplemental Figure). 169 
Representative examples of hind limb stepping presented in here are available 170 
in the supplemental video materials (Supplemental Video 1-3).  171 
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We further analyzed levodopa-induced rotation of 6-OHDA-lesioned mice in 172 
the same experimental condition with the hind limb step analysis. As shown in Figure 3, 173 
a significantly reduced rotation to contralateral-to-lesion side in 6-OHDA mice 174 
compared to control, indicated as % of total (control, 52.9 ± 7.16 ; 6-OHDA, 16.4 ± 175 
8.59; n = 5, P < 0.05 vs. control), was reversed significantly by levodopa in a 176 
dose-dependent manner (1 mg/kg of levodopa, 73.6 ± 13.4; 3 mg/kg of levodopa, 90.9 ± 177 
10.2; n = 5, P < 0.005 vs. 6-OHDA). 178 
Targeting the MFB with 6-OHDA lesions is considered to mimic late stage 179 
PD since it causes a rapid and massive loss of dopaminergic neurons, accompanied by 180 
severe motor deficiency (Ungerstedt, 1968; Iancu et al., 2005; Bové and Perier, 2012; 181 
Heuer et al., 2012; Glajch et al., 2012; Tronci and Francardo, 2018). In fact, as shown in 182 
Figure 1, we confirmed that the mice used in this study expressed features, namely 183 
rotational activity and TH IR, of a hemi-parkinsonism model. These effects can be 184 
easily reproduced regardless of animal species. However, the behavioral tests initially 185 
established in rats are not always directly applicable in mice; rather, modifications are 186 
sometimes needed to optimize experimental conditions and apparatus (Iancu et al., 187 
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2005; Heuer et al., 2012; Glajch et al., 2012). Since the current study design did not 188 
require any additional/modified procedures, we simply video-recorded the spontaneous 189 
hind limb steps of 6-OHDA-lesioned mice. Thus, the current model can be applicable to 190 
both rats and mice under similar conditions. 191 
Although asymmetric use of the hind limbs in unilateral 6-OHDA-lesioned 192 
mice has previously been reported (Glajch et al., 2012), the study was not validated with 193 
a PD therapeutic agent such as levodopa. In the present study, we demonstrated a 194 
reduced use of the contralateral-to-lesioned side of hind limb in unilateral 195 
6-OHDA-lesioned mice. This effect was dose-dependently ameliorated by levodopa 196 
administration (Figure 2), strongly suggesting that the 6-OHDA-induced hind limb step 197 
changes were due to striatal DA deficiency. Thus, in the unilateral 6-OHDA-lesioned 198 
mouse model, abnormal hind limb stepping might reflect motor deficits of the lower 199 
extremities such as bradykinesia, akinesia, and gait disturbance observed in PD patients 200 
(Fahn et al., 1987), and could be utilized to develop and evaluate novel therapeutics of 201 
PD with satisfying face, constructive, and predictive validities, together with the 202 
rotational behavior (Figures 1 and 3). Different dosing of 6-OHDA will further 203 
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characterize the sensitivity of abnormal hind limb stepping with correlation to neuronal 204 
loss in SNpc and striatal denervation, as was previously studied in other behavioral tests 205 
(Boix et al., 2015). It would also be expected to develop a software-based automated 206 
system for counting steps.  207 
Repeated administration of levodopa elicits LID, which has also been 208 
investigated in unilateral 6-OHDA-lesioned animals (Lunblad et al., 2002; Tronci and 209 
Francardo, 2018). Further examination will reveal how LID affects abnormal hind limb 210 
stepping and the scoring of mice according to abnormal involuntary movement scales. 211 
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Legends to Figures 291 
Figure 1: Generation of 6-OHDA-induced hemi-parkinsonism mice. (A) Rotation to 292 
contralateral side indicated as % of total counts in a 30-min test. Values are expressed 293 
as mean ± SEM (n = 5, F2,12 = 363.6, ***P < 0.005 vs. control). One-way ANOVA 294 
followed by Scheffe’s post hoc test. (B) Representative image of TH immunostaining in 295 
the striatum of a unilateral 6-OHDA-lesioned mouse. Scale bar indicates 500 µm. (C) 296 
Quantitative analysis of striatal TH immunoreactivity (IR) indicated by density (A.U., 297 
arbitrary unit). Values are expressed as mean ± SEM (n = 5, ***P < 0.005 vs. 298 
non-lesioned side). Two-tailed t-test. 299 
 300 
Figure 2: Evaluation of hind limb steps. (A) Topological configuration of the analyzed 301 
hind limb. (B) Total count of spontaneous hind limb steps in a 5-min test. Values are 302 
expressed as mean ± SEM (n = 5, F3,16 = 6.24, *P < 0.05 vs. control, #P < 0.05 vs. 303 
6-OHDA). (C) Steps of the contralateral hind limb, indicated as % of total counts. 304 
Values are expressed as mean ± SEM (n = 5, F3,16 = 10.2, *P < 0.05 vs. control, #P < 305 





Figure 3: Evaluation of levodopa-induced rotation. Rotation to contralateral-to-lesion 309 
side indicated as % of total counts in a 5-min test. Values are expressed as mean ± SEM 310 
(n = 5, F3,16 = 10.67, *P < 0.05 vs. control, ###P < 0.005 vs. 6-OHDA). One-way 311 
ANOVA followed by Fisher’s PLSD test. 312 
 313 
Legends to Supplemental Figure 314 
Supplemental Figure: Evaluation of sequential ipsilateral hind limb steps in a 5-min 315 
test. (A) Counts of sequential double steps in the ipsilateral hind limb. Values are 316 
expressed as mean ± SEM (n = 5, F3,16 = 2.83). (B) Counts of sequential triple steps in 317 
the ipsilateral hind limb. Values are expressed as mean ± SEM (n = 5, F3,16 = 7.35, *P < 318 
0.05 vs. control, #P < 0.05 vs. 6-OHDA). One-way ANOVA followed by Scheffe’s post 319 
hoc test. 320 
 321 
Legends to Supplemental Video Materials 322 
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Video 1: Spontaneous steps of a control mouse. 323 
Video 2: Spontaneous steps of a unilateral 6-OHDA-lesioned mouse. The 324 
contralateral-to-lesioned side of the hind limb is indicated by an arrow. 325 
Video 3: Spontaneous steps of a unilateral 6-OHDA-lesioned mouse treated with 1 326 
mg/kg of levodopa. Playback speed was 0.5x. 327 
 328 
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